Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-04-30

FDA Approved: ONDANSETRON — Supplemental Application (West-Ward Pharmaceuticals Corp)

View source ↗

Summary

The FDA approved a supplemental application for ondansetron submitted by West-Ward Pharmaceuticals Corp under ANDA076780, authorizing changes to this generic pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ondansetron (ondansetron)

Snippet

SUPPL AP for ONDANSETRON (ONDANSETRON)